All In Biotech

Drug Trial Radar · NCT05890794

Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Open-Label Pilot Trial to Evaluate the Effects of Ilofotase Alfa on Biomarkers in Adult Patients With Hypophosphatasia

Last checked: Nov 19, 2026Latest source record: Feb 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

May 15, 2023

Primary completion

Jul 7, 2023

Study completion Jul 12, 2023

Sponsor

Lead sponsor
AM-PharmaIndustry
Sponsor type
Industry
First posted
Jun 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to compare the effectiveness of two doses of ilofotase alfa, an enzyme replacement treatment, in patients with hypophosphatasia (HPP). The main question it aims to answer is if the harmful accumulating levels of extracellular inorganic pyrophosphate (PPi) and pyridoxal 5'-phosphate (PLP) can be reduced with ilofotase alfa. Researchers will compare the two doses of ilofotase alfa to see if treatment effects differ between the doses.

Conditions

  • Hypophosphatasia

Interventions

  • Ilofotase Alfa, 0.8 mg/kgBiological

    Biological: single 1-hour intravenous infusion of 0.8 mg/kg ilofotase alfa

  • Ilofotase Alfa, 3.2 mg/kgBiological

    Biological: single 1-hour intravenous infusion of 3.2 mg/kg ilofotase alfa

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Percent Change From Baseline in Extracellular Inorganic Pyrophosphate (PPi)Time frame: Day 1 to Day 10
  2. Maximum Percent Change From Baseline in Pyridoxal 5'-Phosphate (PLP)Time frame: Day 1 to Day 10

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Osteologie / Klinische Studieneinheit, Orthopädische Klinik - KLH

    Würzburg, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.